Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.zenithhealthcare.com | |
Market Cap | 24.67 Cr. | |
Enterprise Value(EV) | 22.80 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.05 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 98.27 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.25 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 1.43 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.21 | Calculated using Price: 4.59 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.37 Cr. | 53,739,000 Shares |
FaceValue | 1 | |
About Zenith Health Care Ltd. | ||
Zenith Healthcare is engaged in the manufacturing of tablets, capsules, ointments, and liquid injectable among others. |
1 Day |
|
+2.46% |
1 Week |
|
+2.92% |
1 Month |
|
+2.00% |
3 Month |
|
+6.02% |
6 Month |
|
+11.98% |
1 Year |
|
+11.44% |
2 Year |
|
-35.67% |
5 Year |
|
+84.68% |
10 Year |
|
+615.62% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -4.06 | -5.45 | -2.78 | 4.95 | 2.38 | 9.27 | 6.64 | 4.44 | 1.08 | |
Return on Capital Employed (%) | -5.82 | -8.24 | -3.04 | 7.38 | 2.95 | 9.68 | 8.56 | 8.85 | 1.74 | |
Return on Assets (%) | -3.73 | -5 | -2.55 | 4.37 | 2.03 | 7.6 | 5.28 | 3.11 | 0.75 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | |
Minority Int. | |||||||||||
Equity & Liab. | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 12 | 9 | 10 | |
Non Curr. Assets | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Curr. Assets | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 10 | 7 | 8 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 12 | 9 | 10 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 4 | 3 | 5 | 10 | 10 | 12 | 14 | 22 | 13 | 13 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | |
Total Income | 4 | 4 | 5 | 10 | 10 | 12 | 14 | 23 | 14 | 13 | |
Total Expenditure | -4 | -4 | -5 | -9 | -10 | -11 | -13 | -22 | -13 | -13 | |
PBIDT | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 1 | 0 | 2 | -1 | 1 | -1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | ||||||||
Net Change | -1 | 0 | 0 | 0 | 0 | 0 | 1 | -2 | 1 | -1 | |
Cash & Cash Eqvt | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 |
Thu, 11 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Mihir Shah Designation: Company Secartary and Compliance Officer EmailId: mahendrazenith@hotmail.com Name of the Chief Financial Officer: Prashant Gupta Designation: Chef Finanical Officer EmailId: zenithaccounts@hotmail.com Date: 11/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
Wed, 10 Apr 2024
Submission Of Share Transfer Etc. Certificate For The Year Ended 31St March 2024 Pursuant To Regulation 40(10) Of The SEBI (LODR ) 2015. Submission of Share Transfer etc. Certificate for the year ended 31st March 2024 pursuant to Regulation 40 (10) of the SEBI (LODR) 2015. |
|||||||||||||||||||||
Wed, 10 Apr 2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024 Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirnments) Regulation 2015 for the Financial Year ended 31st March 2024. |
Mon, 22 Apr 2024 |
High Delivery Percentage |
5 SMA Crossing 20 SMA From Above |
William %R Trending Down |
Bearish Engulfing |
Close Crossing 20 SMA From Above |